Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03230318
Title Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (FIDES-01)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Basilea Pharmaceutica
Indications

intrahepatic cholangiocarcinoma

cholangiocarcinoma

Therapies

Derazantinib

Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN | BEL

Additional content available in CKB BOOST